HBK Sorce Advisory LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
HBK Sorce Advisory LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$129,865
-13.3%
11,109
-0.3%
0.01%0.0%
Q2 2023$149,816
-18.7%
11,147
+0.3%
0.01%
-25.0%
Q1 2023$184,188
+43650.1%
11,109
-51.0%
0.01%
-27.3%
Q4 2022$421
-99.7%
22,652
+103.9%
0.01%
+10.0%
Q3 2022$143,000
+83.3%
11,1090.0%0.01%
+66.7%
Q2 2022$78,000
-15.2%
11,1090.0%0.01%
+20.0%
Q1 2022$92,000
+22.7%
11,1090.0%0.01%
+25.0%
Q4 2021$75,000
+27.1%
11,1090.0%0.00%
+33.3%
Q3 2021$59,000
-7.8%
11,1090.0%0.00%
-25.0%
Q2 2021$64,000
+25.5%
11,1090.0%0.00%
+33.3%
Q1 2021$51,000
+37.8%
11,1090.0%0.00%
+50.0%
Q4 2020$37,000
+12.1%
11,1090.0%0.00%0.0%
Q3 2020$33,000
-35.3%
11,1090.0%0.00%
-50.0%
Q2 2020$51,000
+18.6%
11,1090.0%0.00%0.0%
Q1 2020$43,000
+2.4%
11,1090.0%0.00%0.0%
Q4 2019$42,000
-28.8%
11,1090.0%0.00%
-33.3%
Q3 2019$59,000
+37.2%
11,1090.0%0.01%
+50.0%
Q2 2019$43,000
-24.6%
11,1090.0%0.00%
-33.3%
Q1 2019$57,000
+171.4%
11,1090.0%0.01%
+200.0%
Q4 2018$21,000
-73.8%
11,109
-47.4%
0.00%
-77.8%
Q3 2018$80,000
+21.2%
21,1090.0%0.01%
+12.5%
Q2 2018$66,000
+32.0%
21,1090.0%0.01%
+33.3%
Q1 2018$50,000
-39.8%
21,1090.0%0.01%
-40.0%
Q4 2017$83,000
+56.6%
21,1090.0%0.01%
+25.0%
Q3 2017$53,000
-8.6%
21,1090.0%0.01%
-11.1%
Q2 2017$58,000
+34.9%
21,109
-4.5%
0.01%
+28.6%
Q1 2017$43,000
+95.5%
22,109
+4.7%
0.01%
+75.0%
Q4 2016$22,000
-4.3%
21,1090.0%0.00%
-20.0%
Q3 2016$23,000
+53.3%
21,1090.0%0.01%
+66.7%
Q2 2016$15,000
-40.0%
21,1090.0%0.00%
-50.0%
Q1 2016$25,000
-7.4%
21,109
+90.0%
0.01%
-14.3%
Q4 2015$27,000
-18.2%
11,1090.0%0.01%
-36.4%
Q3 2015$33,000
-28.3%
11,1090.0%0.01%
-31.2%
Q2 2015$46,00011,1090.02%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 208,189$1,726,0003.48%
FRIESS ASSOCIATES LLC 571,940$4,741,0002.53%
GABLES CAPITAL MANAGEMENT INC. 438,764$3,637,0002.28%
Prairiewood Capital, LLC 258,073$2,139,0001.50%
Quantedge Capital Pte Ltd 597,300$4,952,0001.46%
ARMISTICE CAPITAL, LLC 8,372,000$69,404,0001.34%
SummerHaven Investment Management, LLC 158,473$1,314,0000.74%
Capital Impact Advisors, LLC 99,322$823,0000.60%
EAM Investors, LLC 365,415$3,029,0000.56%
GLOBEFLEX CAPITAL L P 304,515$2,524,0000.51%
View complete list of CATALYST PHARMACEUTICALS INC shareholders